%20-%20Tint%20100.png?width=106&name=Logo%20-%20Standard%20-%20Blue%20(270%20x%20149)%20-%20Tint%20100.png){kind=logo}
Innovator Spotlight
Arsenal Medical
Matthew Boyd and Brian Johnson are joined by Dr. Upma Sharma and Carmichael Roberts from Arsenal Medical. They discuss Arsenal Medical’s approach to a few long-standing clinical problems with their novel biomaterials and devices.
Arsenal Medical was founded by serial entrepreneur-investor Carmichael Roberts and academic luminaries Robert Langer and George Whitesides, who have revolutionized the fields of drug delivery, biotech, and clean energy. As experts in materials science and chemistry, they created Arsenal with the broad vision to transform medicine with materials.
×
Please feel out the form below and someone from our team will contact you shortly.
Inside the Episode
Innovator Spotlight
Arsenal Medical
On Point
Upma Sharma on point discussing what it means to be a biomaterials platform company.
On Point
Upma Sharma on point discussing communication during commercialization for a novel biomedical innovation.
On Point
Carmichael Roberts on point discussing the difference between a founder and an entrepreneur.
On Point
Upma Sharma on point discussing commercializing biomaterials as medical devices.
On Point
Upma Sharma and Carmichael Roberts on point discussing the next evolution of biomedical devices from metal to plastic to biomaterials.
On Point
Carmichael Roberts on point discussing biomedical applications that require both biochemical and structural solutions.
On Point
Upma Sharma on point discussing funding biomedical innovation through the commercial stages.
On Point
Carmichael Roberts on point discussing investing in what you know.
On Point
Upma Sharma on point discussing the core technology and commercial status of Arsenal's NeoCast product.
On Point
Carmichael Roberts on point discussing the challenges and benefits of attracting sources of government funding.
On Point
Upma Sharma on point discussing the hurdle of reimbursement for a novel breakthrough device.
On Point
Upma Sharma on point discussing what it means to be a biomaterials platform company.
On Point
Upma Sharma on point discussing communication during commercialization for a novel biomedical innovation.
On Point
Carmichael Roberts on point discussing the difference between a founder and an entrepreneur.
On Point
Upma Sharma on point discussing commercializing biomaterials as medical devices.
On Point
Upma Sharma and Carmichael Roberts on point discussing the next evolution of biomedical devices from metal to plastic to biomaterials.
On Point
Carmichael Roberts on point discussing biomedical applications that require both biochemical and structural solutions.
On Point
Upma Sharma on point discussing funding biomedical innovation through the commercial stages.
On Point
Carmichael Roberts on point discussing investing in what you know.
On Point
Upma Sharma on point discussing the core technology and commercial status of Arsenal's NeoCast product.
On Point
Carmichael Roberts on point discussing the challenges and benefits of attracting sources of government funding.
On Point
Upma Sharma on point discussing the hurdle of reimbursement for a novel breakthrough device.
On Point
Upma Sharma on point discussing what it means to be a biomaterials platform company.
On Point
Upma Sharma on point discussing communication during commercialization for a novel biomedical innovation.
On Point
Carmichael Roberts on point discussing the difference between a founder and an entrepreneur.
Behind the Scenes
Additional Resources
.webp?width=1921&height=1081&name=Content%20Card%20-%20Just%20Mighty%20-%20Boyd%20-%20Two%20Color%20-%20Full%20(1920%20x%201080).webp)
.png?width=401&height=401&name=Logo%20-%20Just%20Mighty%20-%20White%20Logo%20(400%20x%20400).png){kind=logo}
